Current advances in molecular imaging of gene and cell therapy for cancer

Cancer Biology and Therapy

Volumn 4, Issue 5, 2005, Pages 518-523

  Shah, Khalid ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bioluminescence; Fluorescence; Gene therapy; Neural stem cells; Tumors; Virus vectors

Indexed keywords

ANTINEOPLASTIC AGENT; DOXYCYCLINE; FLUCYTOSINE; GANCICLOVIR; GLUCOSE REGULATED PROTEIN 78; NUCLEOSIDE ANALOG; RADIOACTIVE IODINE; SOMATOSTATIN DERIVATIVE; SUPERPARAMAGNETIC IRON OXIDE; THYMIDINE KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS ENZYME;

ADOPTIVE IMMUNOTHERAPY; BACTERIAL GENE; BIOLUMINESCENCE; ENGINEERING; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GLIOBLASTOMA; IN VIVO STUDY; INFRARED RADIATION; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SUICIDE GENE; VIRUS MUTANT;

EID: 25144486195     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.5.1706     Document Type: Review

References (60)

1. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2001; 9:123-8.
2. Shah K, Jacobs A, Breakefield XO, Weissleder R. Molecular imaging of gene therapy for cancer. Gene Ther 2004; 11:1175-87, (Review).
3. Herschman HR. Molecular imaging: Looking at problems, seeing solutions. Science 2003; 302:605-8, (Review).
4. Gambhir S. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2:683-93.
5. Blasberg R, Tjuvajev JG. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. Q J Nucl Med 1999; 43:163-9, (Review).
6. Bogdanov Jr A, Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol 1998; 16:5-10.
7. Herschman HR. Noninvasive imaging of reporter gene expression in living subjects. Adv Cancer Res 2004; 92:29-80, (Review).
8. McCaffrey A, Kay MA, Contag CH. Advancing molecular therapies through in vivo bioluminescent imaging. Mol Imaging 2003; 2:75-86, (Review).
9. Contag CH, Jenkins D, Contag PR, Negrin RS. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2:41-52.
10. Wang, El Diery. 2003, Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil. Cancer Res 2004; 64:6666-72.
11. Rehemtulla A, Taneja N, Ross BD. Bioluminescence detection of cells having stabilized p53 in response to a genotoxic event. Mol Imaging 2004; 3:63-8.
12. Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T, Contag PR. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 2003; 20:733-44.
13. Shah K, Tang Y, Breakefield XO, Weissleder R. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 2003; 22:6865-72.
14. Caceres G, Zankina R, Zhu X, Jiao JA, Wong H, Aller A, Andreotti P. Determination of chemotherapeutic activity in vivo by luminescent imaging of luciferase-transfected human tumors. Anticancer Drugs 2003; 14:569-74.
15. Nyati MK, Symon Z, Kievit E, Dornfeld KJ, Rynkiewicz SD, Ross BD, Rehemtulla A, Lawrence TS. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther 2002; 13:844-9.
16. Pichler A, Prior JL, Piwnica-Worms D. Imaging reversal of multidrug resistance in living mice with bio luminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci USA 2004; 101:1702-7.
17. Ray S, Paulmurugan R, Hildebrandt I, Iyer M, Wu L, Carey M, Gambhir SS. Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. Hum Gene Ther 2004; 15:681-90.
18. Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L, Gambhir SS. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 2004; 10:545-52.
19. Uhrbom L, Nerio E, Holland EC. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med 2004; 10:1257-60.
20. Parr MJ, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin Jr WG, Fine HA. Tumor-selective transgene expression in vivo mediated by an E2F- responsive adenoviral vector. Nat Med 1997; 3:1145-9.
21. Holland EC. Gliomagenesis: Genetic alterations and mouse models. Nat Rev Genet 2001; 2:120-9.
22. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431:1112-7.
23. Shah K, Hsisch G, Breakefield XO. Neural progenitor cells and their role in neuro-oncology. Dev Neurosci 2004; 26:118-30.
24. Shah K, Tang Y, Breakefield X, Weissleder R. In vivo tracking of neuronal progenitor cell migration to glioblastomas. Hum Gene Ther 2003; 14:1247-54.
25. Shah K, Bureau E, Kim D, Yang K, Tang Y, Weissleder R, Breakefield XO. Glioma therapy using NSCs with dual imaging of NSC migration and tumor regression in vivo. Ann Neurol 2005; 57:34-41.
26. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003; 101:640-8.
27. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96:245-54.
28. Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S. HSV-tk gene therapy for human renal cell carcinoma in nude mice. Cancer Gene Ther 2001; 8:529-36.
29. Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 2002; 99:16551-5.
30. Shah K, Tung C-H, Breakefield XO, Weissleder R. In vivo imaging of S-TRAIL mediated tumor regression and apoptosis. Mol Ther 2005; In press.
31. Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grotzinger C. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001; 19:327-31.
32. Weissleder R, Tung C-H, Mahmood U, Bogdanov Jr A. In vivo imaging of tumors with pro tease-activated near-infrared fluorescent probes. Nat Biotech 1999; 17:375-8.
33. Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 2000; 60:4953-4958.
34. Shah K, Tung CH, Chang J, Weissleder R, Breakefield XO. In vivo imaging of HIV-1 protease activity in amplicon vector transduced gliomas. Cancer Res 2004; 64:273-8.
35. Shah K, Tung CH, Yang K, Weissleder R, Breakefield XO. Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. Cancer Res 2004; 64:3236-42.
36. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002; 8:757-60.
37. Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov Jr A, Josephson L, Weissleder R. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci USA 2004; 101:12294-9.
38. Price P. PET as a potential tool for imaging molecular mechanisms of oncology in man. Trends Mol Med 2001; 7:442-6.
39. Jacobs AH, Winkeler A, Hartung M, Slack M, Dittmar C, Kummer C, Knoess C, Galldiks N, Vollmar S, Wienhard K, Heiss WD. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum Gene Ther 2003; 14:277-97.
40. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, DiResta G, Daghighian F, Augensen F, Koutcher J, Zweit J, Humm J, Larson SM, Finn R, Blasberg R. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998; 58:4333-41.
41. Gambhir SS, Bauer E, Black ME, Liang Q, Kokoris MS, Barrio JR, Iyer M, Namavari M, Phelps ME, Herschman HR. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 2000; 97:2785-90.
42. Liang Q, Nguyen K, Satyamurthy N, Barrio JR, Phelps ME, Gambhir SS, Herschman HR. Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message positron emission tomography, following gene transfer with adenovirus. Mol Ther 2002; 6:73-82.
43. Rogers BE, Zinn KR, Lin CY, Chaudhuri TR, Buchsbaum DJ. Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector. Cancer 2002; 15:1298-305.
44. Niu G, Gaut AW, Ponto LL, Hichwa RD, Madsen MT, Graham MM, Domann FE. Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J Nucl Med 2004; 45:445-9.
45. Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 2005; 12:329-39.
46. Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H, Gazit-Bornstein G, Gordon EM, Gomer C, Hall FL, Gambhir SS, Lee AS. Spontaneous and controllable activation of suicide gene expression dri ven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Hum Gene Ther 2004; 15:553-61.
47. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): Functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr 1994; 4:1-18, (Review).
48. Plumb JA, Bilsland A, Kakani R, et al Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene 2001; 20:7797-803.
49. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Keith WN, Vassaux G. Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res 2004; 64:4906-11.
50. Dubey P, Su H, Adonai N, Du S, Rosato A, Braun J, Gambhir SS, Witte ON. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA 2003; 100:1232-7.
51. Kim YJ, Dubey P, Ray P, Gambhir SS, Witte ON. Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. Mol Imaging Biol 2004; 6:331-40.
52. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001; 358:727-9.
53. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6:351-5.
54. Ichikawa T, Hogemann D, Saeki Y, Tyminski E, Terada K, Weissleder R, Chiocca EA, Basilion JP. MRI of transgene expression: Correlation to therapeutic gene expression. Neoplasia 2002; 4:523-30.
55. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003; 63:6838-46.
56. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005; 105:420-5.
57. Hamstra DA, Lee KC, Tychewicz JM, Schepkin VD, Moffat BA, Chen M, Dornfeld KJ, Lawrence TS, Chenevert TL, Ross BD, Gelovani JT, Rehemtulla A. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther 2004; 10:916-28.
58. Blackstock AW, Lightfoot H, Case LD, Tepper JE, Mukherji SK, Mitchell BS, Swarts SG, Hess SM. Tumor uptake and elimination of 2′,2′-difluoro- 2′-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: Correlation with in vivo tumor response. Clin Cancer Res 2001; 7:3263-8.
59. Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R, Langford G, Murray N, Yla-Herttuala S. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: A randomised, controlled study. Mol Ther 2004; 10:967-72.
60. Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther 2004; 10:958-66.